Ignite Creation Date:
2024-05-05 @ 4:50 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00326027
Status:
COMPLETED
Last Update Posted:
2012-05-07
First Post:
2006-05-15
Brief Title:
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Non-erosive Reflux or Gastroesophageal Reflux Disease BY1023DE-004
Sponsor:
Nycomed
Organization:
Nycomed
Study Overview
Official Title:
Profi-Study Symptom Reduction in Hospitalized Patients Suffering From Symptomatic Non-erosive or Erosive Gastroesophageal Reflux Disease Treated With Pantoprazole 20 or 40 mg od for 7 Days
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of the study is to evaluate the effect of pantoprazole on fast symptom reduction in hospitalized patients with NERD non-erosive reflux disease or GERD gastroesophageal reflux disease Los Angeles LA Grade A-D During the study the patients will complete a patient-orientated self-assessed reflux questionnaire ReQuest The study duration consists of a treatment period of 7 days 3 days Pantoprazole tablet will be administered once daily in the morning to patients with NERD or GERD at one dose level for each indication The study will provide further data on the safety and tolerability of pantoprazole
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None